What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions
- PMID: 35746474
- PMCID: PMC9228524
- DOI: 10.3390/vaccines10060866
What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions
Abstract
COVID-19 vaccines have been used to counteract the global COVID-19 pandemic. While these are effective, adverse reactions have been reported, such as injection-site pain, muscle ache, fever, palpitation, and chest discomfort. The release of inflammatory cytokines, such as interleukin (IL)-6 and IL-1β, is a potential mechanism for post-vaccine side-effects. Chest discomfort after the vaccination, including myocarditis and acute coronary syndrome, is a particularly serious adverse reaction. It is important to be familiar with the differential diagnoses of chest discomfort and organ-specific diseases associated with COVID-19 vaccines as the preparation for booster shots and vaccinations among children aged 5-11 years begins. High-intensity exercise, alcohol, tobacco smoking, and baths promote inflammatory cytokines, such as IL-6, which may exacerbate the adverse reactions after vaccination. Japanese data show that deaths during baths are the most common for several days after mRNA vaccination. Additionally, alcohol and tobacco smoking were identified as predictive factors of lower antibody titers after vaccination. In this review, we aimed to provide a few recommendations to prevent vaccine-associated disease.
Keywords: COVID-19 vaccination; adverse reaction; autoimmunity; cardiovascular diseases; exercise; inflammatory cytokine; lipid nanoparticles; precautionary measures; taking a bath; vaccine-associated diseases.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches.Diseases. 2024 Oct 1;12(10):231. doi: 10.3390/diseases12100231. Diseases. 2024. PMID: 39452475 Free PMC article. Review.
-
Anaphylaxis is a rare reaction in COVID-19 vaccination.J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21. J Biol Regul Homeost Agents. 2021. PMID: 34105336
-
Clinical Features of Patients Presenting to the Emergency Department With Cardiovascular Adverse Reactions After COVID-19 mRNA Vaccination.J Korean Med Sci. 2022 Mar 7;37(9):e73. doi: 10.3346/jkms.2022.37.e73. J Korean Med Sci. 2022. PMID: 35257528 Free PMC article.
-
Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel.Ann Acad Med Singap. 2021 Nov;50(11):827-837. doi: 10.47102/annals-acadmedsg.2021345. Ann Acad Med Singap. 2021. PMID: 34877586
-
Allergic reactions to Japanese encephalitis vaccine.Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4. Immunol Allergy Clin North Am. 2003. PMID: 14753386 Review.
Cited by
-
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches.Diseases. 2024 Oct 1;12(10):231. doi: 10.3390/diseases12100231. Diseases. 2024. PMID: 39452475 Free PMC article. Review.
-
SARS-CoV-2 vaccination in androgen sensitive phenotypes - A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients.Front Immunol. 2022 Sep 2;13:919958. doi: 10.3389/fimmu.2022.919958. eCollection 2022. Front Immunol. 2022. PMID: 36119091 Free PMC article.
-
The lymphatic system and COVID-19 vaccines.Front Immunol. 2022 Oct 20;13:1041025. doi: 10.3389/fimmu.2022.1041025. eCollection 2022. Front Immunol. 2022. PMID: 36341444 Free PMC article. Review.
-
SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry.Biomedicines. 2023 Jul 7;11(7):1937. doi: 10.3390/biomedicines11071937. Biomedicines. 2023. PMID: 37509576 Free PMC article.
-
Graves' Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later.Vaccines (Basel). 2023 May 3;11(5):934. doi: 10.3390/vaccines11050934. Vaccines (Basel). 2023. PMID: 37243038 Free PMC article.
References
-
- Dunkle L.M., Kotloff K.L., Gay C.L., Anez G., Adelglass J.M., Barrat Hernandez A.Q., Harper W.L., Duncanson D.M., McArthur M.A., Florescu D.F., et al. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N. Engl. J. Med. 2022;386:531–543. doi: 10.1056/NEJMoa2116185. - DOI - PMC - PubMed
-
- Menni C., Klaser K., May A., Polidori L., Capdevila J., Louca P., Sudre C.H., Nguyen L.H., Drew D.A., Merino J., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect. Dis. 2021;21:939–949. doi: 10.1016/S1473-3099(21)00224-3. - DOI - PMC - PubMed
-
- Rosenblum H.G., Gee J., Liu R., Marquez P.L., Zhang B., Strid P., Abara W.E., McNeil M.M., Myers T.R., Hause A.M., et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: An observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect. Dis. 2022 doi: 10.1016/S1473-3099(22)00054-8. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources